MTOR and breast carcinoma: Insulin-like growth factor-1 receptor (IGF-1R) is indicated in breast cancer development, progression, and metastasis through its involvement in Ras/Raf/MEK1/2/ERK1/2 and PI3K/AKT/mTOR pathway (89).